These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 27476704)
1. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013-2015). Patil R; Patil SA; Beaman KD; Patil SA Future Med Chem; 2016 Jul; 8(11):1291-316. PubMed ID: 27476704 [TBL] [Abstract][Full Text] [Related]
2. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents. Patil SA; Patil R; Miller DD Future Med Chem; 2012 Oct; 4(16):2085-115. PubMed ID: 23157240 [TBL] [Abstract][Full Text] [Related]
3. Indole, a core nucleus for potent inhibitors of tubulin polymerization. Brancale A; Silvestri R Med Res Rev; 2007 Mar; 27(2):209-38. PubMed ID: 16788980 [TBL] [Abstract][Full Text] [Related]
5. New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors. La Regina G; Bai R; Coluccia A; Naccarato V; Famiglini V; Nalli M; Masci D; Verrico A; Rovella P; Mazzoccoli C; Da Pozzo E; Cavallini C; Martini C; Vultaggio S; Dondio G; Varasi M; Mercurio C; Hamel E; Lavia P; Silvestri R Eur J Med Chem; 2018 May; 152():283-297. PubMed ID: 29730191 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization. Romagnoli R; Prencipe F; Oliva P; Kimatrai Salvador M; Brancale A; Ferla S; Hamel E; Viola G; Bortolozzi R; Persoons L; Balzarini J; Liekens S; Schols D Bioorg Chem; 2020 Apr; 97():103665. PubMed ID: 32086053 [TBL] [Abstract][Full Text] [Related]
7. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents. Ahmadi S; Habibpour E Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182 [TBL] [Abstract][Full Text] [Related]
8. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization. Coluccia A; Sabbadin D; Brancale A Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885 [TBL] [Abstract][Full Text] [Related]
9. Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure-activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study. Saruengkhanphasit R; Butkinaree C; Ornnork N; Lirdprapamongkol K; Niwetmarin W; Svasti J; Ruchirawat S; Eurtivong C Bioorg Chem; 2021 May; 110():104795. PubMed ID: 33730670 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties. Diao PC; Li Q; Hu MJ; Ma YF; You WW; Hong KH; Zhao PL Eur J Med Chem; 2017 Jul; 134():110-118. PubMed ID: 28410492 [TBL] [Abstract][Full Text] [Related]
12. Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization. Wang SY; Liu X; Meng LW; Li MM; Li YR; Yu GX; Song J; Zhang HY; Chen P; Zhang SY; Hu T Bioorg Med Chem Lett; 2021 Jul; 43():128095. PubMed ID: 33965530 [TBL] [Abstract][Full Text] [Related]
13. Indole based Tubulin Polymerization Inhibitors: An Update on Recent Developments. Sunil D; Kamath PR Mini Rev Med Chem; 2016; 16(18):1470-1499. PubMed ID: 27468786 [TBL] [Abstract][Full Text] [Related]
14. Indole derivatives (2010-2020) as versatile tubulin inhibitors: synthesis and structure-activity relationships. Naaz F; Neha K; Haider MR; Shafi S Future Med Chem; 2021 Oct; 13(20):1795-1828. PubMed ID: 34468201 [TBL] [Abstract][Full Text] [Related]
15. 4- and 5-aroylindoles as novel classes of potent antitubulin agents. Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504 [TBL] [Abstract][Full Text] [Related]
16. Structural insights into the design of indole derivatives as tubulin polymerization inhibitors. Li Y; Yang J; Niu L; Hu D; Li H; Chen L; Yu Y; Chen Q FEBS Lett; 2020 Jan; 594(1):199-204. PubMed ID: 31369682 [TBL] [Abstract][Full Text] [Related]
17. New indole-based chalconoids as tubulin-targeting antiproliferative agents. Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629 [TBL] [Abstract][Full Text] [Related]
18. New ligands of the tubulin colchicine site based on X-ray structures. Álvarez R; Medarde M; Peláez R Curr Top Med Chem; 2014; 14(20):2231-52. PubMed ID: 25434358 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of indole-2-carbohydrazides and thiazolidinyl-indole-2-carboxamides as potent tubulin polymerization inhibitors. Kazan F; Yagci ZB; Bai R; Ozkirimli E; Hamel E; Ozkirimli S Comput Biol Chem; 2019 Jun; 80():512-523. PubMed ID: 31185422 [TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors. Hu MJ; Zhang B; Yang HK; Liu Y; Chen YR; Ma TZ; Lu L; You WW; Zhao PL Chem Biol Drug Des; 2015 Dec; 86(6):1491-500. PubMed ID: 26177395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]